Preora Healthcare Competitors and Similar CompaniesClear all

Preora Healthcare's competitors and similar companies include Leica Biosystems Nussloch, Simphotek, AroCell and Check-Cap.

	Preora Healthcare Preora Healthcare (formerly Preora Diagnostics) is a medical device company developing technology for the early detection and treatment of cancer.	Leica Biosystems Nussloch Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.	Simphotek Simphotek is a biotechnology company developing medical devices for light-based cancer treatments.	AroCell AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors.	Check-Cap Check-Cap is a medical diagnostics company.
Founding Date	Founding Date 2015	Founding Date 1989	Founding Date 2007	Founding Date 2003	Founding Date 2005
Type	Type Private	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare medical devices medical diagnostics medtech oncology	Tags Manufacturing & Industrial medical devices medical diagnostics oncology	Tags Healthcare medical devices medical diagnostics medtech oncology	Tags Healthcare medical devices medical diagnostics medtech oncology	Tags Healthcare medical devices medical diagnostics medtech oncology
Locations	Locations Evanston, US HQ	Locations Nußloch, DE HQ Mumbai, IN Buffalo Grove, US Deer Park, US	Locations Newark, US HQ	Locations Uppsala, SE HQ	Locations Isfiya, IL HQ New York, US
Employees	Employees 1	Employees 38918% increase	Employees 5	Employees 20	Employees 85
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 11 m	Valuation ($) 7 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $254.8m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) kr53.1m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $154.7m (FY, 2022)	Cost of goods N/A	Cost of goods kr21.8m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $100.1m (FY, 2022)	Gross profit N/A	Gross profit kr31.4m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $32.6m (FY, 2022)	Net income N/A	Net income (kr12.2m) (FY, 2025)	Net income $4.1m (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 56.1k	Total funding raised $ 39.3m